13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q1 2025 · Filed May 7, 2025 · Accession 0000904454-25-000238
Total Value
$341.9M
Positions
20
Other Managers
1
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $118.4M | 34.65% |
| 2 | CVRx, Inc. | CVRX | 4,103,430 | $50.2M | 14.68% |
| 3 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $45.0M | 13.17% |
| 4 | Legend Biotech Corporation | LEGN | 814,586 | $27.6M | 8.08% |
| 5 | Rapport Therapeutics, Inc. | RAPP | 2,498,051 | $25.1M | 7.33% |
| 6 | Procept BioRobotics Corporation | PRCT | 357,939 | $20.9M | 6.10% |
| 7 | Nanobiotix S.A. | NBTX | 5,623,816 | $20.1M | 5.89% |
| 8 | Contineum Therapeutics Inc. | CTNM | 1,979,173 | $13.8M | 4.04% |
| 9 | Xencor, Inc. | XNCR | 748,062 | $8.0M | 2.33% |
| 10 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $3.2M | 0.92% |
| 11 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $2.7M | 0.78% |
| 12 | Rallybio Corporation | RLYB | 3,636,363 | $2.4M | 0.70% |
| 13 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $1.8M | 0.54% |
| 14 | Nano-X Imaging Ltd. | NNOX | 158,852 | $793,466 | 0.23% |
| 15 | Vor Biopharma, Inc. | VOR | 1,074,658 | $771,067 | 0.23% |
| 16 | Lyell Immunopharma Inc. | LYEL | 823,317 | $442,945 | 0.13% |
| 17 | Standard BioTools Inc | LAB | 311,967 | $336,924 | 0.10% |
| 18 | Adicet Bio, Inc. | ACET | 364,472 | $275,176 | 0.08% |
| 19 | BiomX Inc. | PHGE | 96,866 | $53,828 | 0.02% |
| 20 | Senseonics Holdings, Inc. | SENS | 54,621 | $35,837 | 0.01% |